ICL Historical Income Statement

ICL Stock

USD 5.88 0.03 0.51%

Historical analysis of ICL Israel income statement accounts such as Selling General Administrative of 370.7 M or Total Revenue of 5.7 B can show how well ICL Israel Chemicals performed in making a profits. Evaluating ICL Israel income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of ICL Israel's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining ICL Israel Chemicals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ICL Israel Chemicals is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About ICL Income Statement Analysis

ICL Israel Chemicals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to ICL Israel shareholders. The income statement also shows ICL investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

ICL Israel Income Statement Chart

At this time, ICL Israel's Depreciation And Amortization is quite stable compared to the past year. Selling General Administrative is expected to rise to about 370.7 M this year, although the value of Total Revenue will most likely fall to about 5.7 B.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts ICL Israel Chemicals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of ICL Israel Chemicals minus its cost of goods sold. It is profit before ICL Israel operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ICL Israel Chemicals. It is also known as ICL Israel overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from ICL Israel's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2022	2023	2024	2025 (projected)
Interest Expense	327M	160M	184M	119.6M
Depreciation And Amortization	481.2M	536M	616.4M	647.2M

Interest Expense Depreciation And Amortization

ICL Israel income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.35	-0.02	0.44	0.39	0.48	0.24	0.06	0.36	0.29	0.43	0.49	0.23	-0.53	0.16	0.3	0.35	-0.46	0.25	0.38	-0.25	-0.27	0.68
Interest Expense	0.35		-0.53	0.44	0.42	0.45	0.29	0.31	0.06	0.39	0.4	0.45	0.26	-0.49	0.12	0.48	0.69	-0.17	0.26	0.55	0.41	0.31	0.49
Selling General Administrative	-0.02	-0.53		0.01	0.09	-0.06	0.1	0.03	0.38	0.03	-0.08	0.0	0.15	0.48	0.22	0.0	-0.77	-0.22	0.06	-0.14	-0.12	-0.21	-0.36
Total Revenue	0.44	0.44	0.01		0.94	0.91	0.81	0.78	0.63	0.87	0.93	0.63	0.8	-0.17	0.73	0.81	0.59	-0.49	0.6	0.73	0.34	0.29	0.54
Gross Profit	0.39	0.42	0.09	0.94		0.74	0.93	0.88	0.51	0.95	0.76	0.51	0.93	-0.14	0.86	0.93	0.46	-0.57	0.74	0.83	0.51	0.36	0.41
Other Operating Expenses	0.48	0.45	-0.06	0.91	0.74		0.49	0.48	0.72	0.59	0.97	0.83	0.48	-0.2	0.39	0.55	0.64	-0.4	0.27	0.51	0.05	0.06	0.62
Operating Income	0.24	0.29	0.1	0.81	0.93	0.49		0.97	0.31	0.99	0.58	0.16	1.0	-0.08	0.98	0.91	0.34	-0.47	0.87	0.8	0.65	0.53	0.26
Ebit	0.06	0.31	0.03	0.78	0.88	0.48	0.97		0.27	0.97	0.58	0.1	0.97	-0.01	0.95	0.88	0.36	-0.35	0.81	0.76	0.71	0.58	0.2
Research Development	0.36	0.06	0.38	0.63	0.51	0.72	0.31	0.27		0.36	0.68	0.65	0.32	0.36	0.3	0.28	0.11	-0.3	0.06	0.15	-0.1	-0.16	0.08
Ebitda	0.29	0.39	0.03	0.87	0.95	0.59	0.99	0.97	0.36		0.68	0.24	0.98	-0.13	0.94	0.92	0.44	-0.43	0.84	0.81	0.63	0.52	0.34
Cost Of Revenue	0.43	0.4	-0.08	0.93	0.76	0.97	0.58	0.58	0.68	0.68		0.68	0.56	-0.18	0.49	0.58	0.66	-0.34	0.38	0.53	0.13	0.18	0.61
Total Operating Expenses	0.49	0.45	0.0	0.63	0.51	0.83	0.16	0.1	0.65	0.24	0.68		0.15	-0.2	0.02	0.37	0.44	-0.44	-0.05	0.35	-0.15	-0.28	0.49
Income Before Tax	0.23	0.26	0.15	0.8	0.93	0.48	1.0	0.97	0.32	0.98	0.56	0.15		-0.04	0.98	0.91	0.3	-0.48	0.87	0.79	0.64	0.52	0.23
Total Other Income Expense Net	-0.53	-0.49	0.48	-0.17	-0.14	-0.2	-0.08	-0.01	0.36	-0.13	-0.18	-0.2	-0.04		0.04	-0.16	-0.55	0.23	-0.23	-0.38	0.1	0.01	-0.83
Net Income	0.16	0.12	0.22	0.73	0.86	0.39	0.98	0.95	0.3	0.94	0.49	0.02	0.98	0.04		0.81	0.19	-0.43	0.83	0.66	0.6	0.52	0.13
Income Tax Expense	0.3	0.48	0.0	0.81	0.93	0.55	0.91	0.88	0.28	0.92	0.58	0.37	0.91	-0.16	0.81		0.43	-0.51	0.82	0.94	0.68	0.44	0.34
Selling And Marketing Expenses	0.35	0.69	-0.77	0.59	0.46	0.64	0.34	0.36	0.11	0.44	0.66	0.44	0.3	-0.55	0.19	0.43		-0.2	0.31	0.54	0.21	0.31	0.71
Minority Interest	-0.46	-0.17	-0.22	-0.49	-0.57	-0.4	-0.47	-0.35	-0.3	-0.43	-0.34	-0.44	-0.48	0.23	-0.43	-0.51	-0.2		-0.55	-0.56	-0.02	-0.01	-0.39
Net Income From Continuing Ops	0.25	0.26	0.06	0.6	0.74	0.27	0.87	0.81	0.06	0.84	0.38	-0.05	0.87	-0.23	0.83	0.82	0.31	-0.55		0.84	0.62	0.58	0.34
Tax Provision	0.38	0.55	-0.14	0.73	0.83	0.51	0.8	0.76	0.15	0.81	0.53	0.35	0.79	-0.38	0.66	0.94	0.54	-0.56	0.84		0.6	0.4	0.52
Interest Income	-0.25	0.41	-0.12	0.34	0.51	0.05	0.65	0.71	-0.1	0.63	0.13	-0.15	0.64	0.1	0.6	0.68	0.21	-0.02	0.62	0.6		0.81	-0.12
Net Interest Income	-0.27	0.31	-0.21	0.29	0.36	0.06	0.53	0.58	-0.16	0.52	0.18	-0.28	0.52	0.01	0.52	0.44	0.31	-0.01	0.58	0.4	0.81		-0.05
Reconciled Depreciation	0.68	0.49	-0.36	0.54	0.41	0.62	0.26	0.2	0.08	0.34	0.61	0.49	0.23	-0.83	0.13	0.34	0.71	-0.39	0.34	0.52	-0.12	-0.05

Click cells to compare fundamentals

ICL Israel Account Relationship Matchups

ICL Israel income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	612.7M	523.9M	481.2M	536M	616.4M	647.2M
Interest Expense	219M	216M	327M	160M	184M	119.6M
Selling General Administrative	232M	276M	291M	260M	299M	370.7M
Total Revenue	5.0B	7.0B	10.0B	7.5B	8.7B	5.7B
Gross Profit	1.5B	2.6B	5.0B	2.7B	3.1B	2.2B
Other Operating Expenses	4.8B	5.7B	6.5B	6.4B	7.4B	4.6B
Operating Income	202M	1.2B	3.5B	1.1B	1.3B	1.1B
Ebit	208.3M	1.1B	3.6B	1.1B	1.3B	1.1B
Research Development	54M	64M	68M	71M	81.7M	61.5M
Ebitda	821M	1.7B	4.0B	1.7B	1.9B	1.4B
Cost Of Revenue	3.6B	4.3B	5.0B	4.9B	5.6B	3.5B
Total Operating Expenses	1.3B	1.4B	1.5B	1.5B	1.8B	1.1B
Income Before Tax	49M	1.1B	3.4B	974M	1.1B	968.1M
Total Other Income Expense Net	(153M)	(118M)	(112M)	(167M)	(150.3M)	(142.8M)
Net Income	24M	783M	2.2B	647M	744.1M	751.3M
Income Tax Expense	25M	260M	1.2B	287M	330.1M	217.1M
Selling And Marketing Expenses	766M	1.1B	1.2B	1.1B	1.3B	711.5M
Net Income Applicable To Common Shares	475M	11M	783M	2.2B	2.5B	2.6B
Minority Interest	158M	(49M)	(60M)	(34M)	(30.6M)	(29.1M)
Net Income From Continuing Ops	24M	832M	2.2B	945M	1.1B	770.3M
Tax Provision	25M	260M	1.2B	412M	473.8M	309.6M
Interest Income	61M	94M	214M	39M	44.9M	42.6M
Net Interest Income	(140M)	(158M)	(122M)	(113M)	(161M)	(169.1M)
Reconciled Depreciation	489M	490M	498M	526M	604.9M	509.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:

How To Invest In ICL

Details

Is ICL Stock a good investment?

Details

What is ICL Israel's Net Worth?

Details

Largest Fertilizers & Agricultural Chemicals Companies

View

Largest Agricultural Inputs Companies

View

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.18)

Dividend Share

0.2

Earnings Share

0.31

Revenue Per Share

5.373

Quarterly Revenue Growth

(0.06)

The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICL Historical Income Statement

About ICL Income Statement Analysis

ICL Israel Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

ICL Israel income statement Correlations

ICL Israel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICL Israel income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Operating Income
Ebitda	+ 0.99	Operating Income
Net Income	+ 0.98	Operating Income
Income Before Tax	+ 0.98	Ebitda
Net Income	+ 0.98	Income Before Tax
Cost Of Revenue	+ 0.97	Other Operating Expenses

Reconciled Depreciation	- 0.83	Total Other Income Expense Net
Selling And Marketing Expenses	- 0.77	Selling General Administrative
Minority Interest	- 0.57	Gross Profit
Tax Provision	- 0.56	Minority Interest
Net Income From Continuing Ops	- 0.55	Minority Interest
Selling And Marketing Expenses	- 0.55	Total Other Income Expense Net